You are currently viewing a new version of our website. To view the old version click .

Microalgae Secondary Metabolites-Bioactivity Determination using Innovative Approach of Omics

This special issue belongs to the section “Natural Products Chemistry“.

Special Issue Information

Dear Colleagues,

Microalgae have kept developing new adaptation features and defense mechanisms; one of these survival strategies is the production of a vast variety of secondary metabolites, exhibiting a broad spectrum of biological activities and properties, including peptides, lipopeptides, polyketides, alkaloids, lipids, and terpenoids. When growth conditions are advantageous, microalgae proliferate, resulting in overgrown populations known as algal blooms, which can be harmful for aquatic life as well as for human health because of the toxins they produce. The recent advancement in the field of metabolomics and genomics has accelerated the discovery of new bioactive molecules and toxins. Additionally, the role of bacterial–microalgal interactions on the physiological control of metabolite production towards the development of co-habitation in non-axenic microalgae are scantly reported.

The current Special Issue of Molecules welcomes any research highlighting natural algal products, including the molecular mechanism behind the regulation of metabolite production. Moreover, studies describing the biosynthesis of these compounds are especially encouraged.

Dr. Kumar Saurav
Dr. Subhasish Saha
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Cyanobacteria
  • Anti-microbial activity
  • Biosynthesis of bioactive lead molecules
  • Anti-Virulence drug therapy
  • Toxins production and its detection
  • Host-microbe interaction mechanism
  • Dereplication strategy for metabolites

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Molecules - ISSN 1420-3049